India Observers

  Taiwan’s Allegiance Group has announced a significant ₹1,000 crore investment to establish the India–Taiwan Industrial Technology Innovation Park (ITIP) in Karnataka.  The project aims to create a dedicated hub for advanced manufacturing, semiconductor-related industries and smart technology solutions, strengthening India’s growing collaboration with Taiwan in high-tech sectors. The ITIP is expected to boost local employment, attract global supply-chain partners and position Karnataka as a major destination for next-generation industrial innovation.

 Sudarshan Pharma IPO is a BSE SME IPO. The company aims to raise ₹50.10 crores via IPO. The unit is priced at ₹71 to ₹73 per equity share. The IPO will be listed on BSE. The Sudarshan Pharma Initial Public Offering (IPO) date has been set for March 9 and March 14, 2023.  A BSE SME IPO to raise $50.10 crores is Sudarshan Pharma. With a market lot of 1600 shares, the Sudarshan Pharma IPO price range is set at 71 to 73 rupees. The Sudarshan Pharma Industries Limited (SPIL) has expanded its line of products to include specialty chemicals and intermediates that have a variety of uses in the adhesive, paint, and food industries.  Both the domestic and foreign markets are where they are present. They export their goods to the MENA region, Taiwan, Uzbekistan, Syria, Australia, and the UK. Additionally, Sudarshan Pharma engages in contract manufacturing, outsourcing, and the distribution of generic pharmaceutical formulations and medications to hospitals, government agencies, and...